Dr Leah Kirumbi has been appointed as the Chief Medical Advisor for iZola, a pioneering health-tech startup that provides solutions for parents of neurodivergent children, including those with Autism Spectrum Disorder (ASD).

Dr Kirumbi is renowned for her contributions to maternal and child healthcare, including performing Kenya’s first in vitro fertilization (IVF) procedure in 2004.

With over 30 years of experience in maternal and child health and policy development across East Africa, Dr. Kirumbi brings a wealth of professional expertise to her new role at iZola.

She also has over 40 years of personal experience as a mother and primary caregiver to a neurodivergent dependent, offering a unique perspective that combines professional excellence with deep personal commitment.

Dr Wamuyu Owotoki, CEO of iZola, emphasized the strategic significance of this appointment.

Read More

  1. AERC Summit to explore Africa's US$65 billion FinTech growth by 2030
  2. KCB Group post-tax profits soars by 49 per cent to Sh45.8 billion in Q3 2024
  3. Tanzanian giant AMSONS Group secures green light for Bamburi Cement takeover

“The appointment is fundamentally aligned to iZola’s strategic direction which endeavors to further our mission to transform health journeys for families with special needs. Her experience as premier mother and child specialist and wealth of knowledge will be instrumental in driving iZola’s aggressive strategic plan," Owotoki stated.

"It should bring great comfort to families that Dr. Leah Kirumbi also comes with the dedication and empathy that can only be forged from being in the trenches faithfully everyday caring for a neurodivergent child for over four decades. Her expertise and dedication to upholding the highest standards of medical care align closely with our mission and values will play a pivotal role in ensuring that we continue to provide our customers with excellent solutions that meet their needs."

Dr. Kirumbi expressed her enthusiasm for her new role, stating, “I am honoured and privileged to be appointed as the Chief Medical Advisor of iZola. I am confident that in line with our strategic plan, iZola will continue to further simplify the healthcare journey for children with special needs and their caregivers through continuous product innovation that leverages AI technology."

Her appointment is set to strengthen iZola’s mission to provide exceptional support and innovative health solutions for families with neurodivergent children, ensuring that the company’s offerings are both effective and empathetic.